Synergy of clavulanic acid, sulbactam and tazobactam (YTR 830) with amoxycillin against fifty beta-lactamase-producing strains of Haemophilus influenzae.
作者信息
Simonet M, Moittie D, Philippon A, Descamps P, Veron M
机构信息
Service de Microbiologie, CHU Necker-Enfants Malades, Paris, France.
出版信息
J Antimicrob Chemother. 1989 May;23(5):798-800. doi: 10.1093/jac/23.5.798.
PMID:2547748
Abstract
摘要
相似文献
1
Synergy of clavulanic acid, sulbactam and tazobactam (YTR 830) with amoxycillin against fifty beta-lactamase-producing strains of Haemophilus influenzae.
J Antimicrob Chemother. 1989 May;23(5):798-800. doi: 10.1093/jac/23.5.798.
2
3
In vitro activity of YTR 830.YTR 830的体外活性。
J Chemother. 1989 Jun;1(3):151-4. doi: 10.1080/1120009x.1989.11738883.
4
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.β-内酰胺酶抑制剂YTR 830、克拉维酸钠和舒巴坦与阿莫西林或氨苄西林联合使用的比较活性。
Antimicrob Agents Chemother. 1984 Oct;26(4):580-2. doi: 10.1128/AAC.26.4.580.
5
Beta-lactamase inhibitors and Acinetobacter spp.β-内酰胺酶抑制剂与不动杆菌属
J Antimicrob Chemother. 1990 Sep;26(3):449-51. doi: 10.1093/jac/26.3.449.
6
Antibacterial characteristics of YTR 830, a sulfone beta-lactamase inhibitor, compared with those of clavulanic acid and sulbactam.与棒酸和舒巴坦相比，砜类β-内酰胺酶抑制剂YTR 830的抗菌特性
Antimicrob Agents Chemother. 1988 Jun;32(6):925-7. doi: 10.1128/AAC.32.6.925.
7
Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.哌拉西林与β-内酰胺酶抑制剂他唑巴坦、克拉维酸和舒巴坦联合使用的体外和体内比较活性。
Antimicrob Agents Chemother. 1989 Nov;33(11):1964-9. doi: 10.1128/AAC.33.11.1964.
8
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.β-内酰胺酶抑制剂YTR 830、克拉维酸和舒巴坦与氨苄西林及广谱青霉素联合应用对特定产β-内酰胺酶需氧革兰氏阴性杆菌的比较活性
Antimicrob Agents Chemother. 1986 Jun;29(6):980-5. doi: 10.1128/AAC.29.6.980.
9
Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.阿莫西林-克拉维酸、氨苄西林-舒巴坦和哌拉西林-他唑巴坦对携带已知β-内酰胺酶的大肠杆菌和奇异变形杆菌菌株的体外比较活性。
Infection. 1991 Mar-Apr;19(2):106-9. doi: 10.1007/BF01645578.
10
Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.他唑巴坦、舒巴坦和克拉维酸增强氨苄西林对肠杆菌科临床分离株抗菌效力的相对疗效
Eur J Clin Microbiol Infect Dis. 1993 Mar;12(3):200-5. doi: 10.1007/BF01967112.
引用本文的文献
1
Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.哌拉西林/他唑巴坦：抗菌活性、药代动力学特性及治疗潜力综述
Drugs. 1994 Mar;47(3):506-35. doi: 10.2165/00003495-199447030-00008.
Zotero 插件